Global Contraceptives Drugs and Devices Market Research Report 2023

Publisher Name :
Date: 01-Dec-2023
No. of pages: 97
Inquire Before Buying

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Contraceptives Drugs and Devices market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

By Company

- Teva Pharmaceutical Industries Ltd

- Church & Dwight Co. Inc

- Reckitt Benckiser Plc

- Pfizer, Inc

- Bayer AG

- Mayer Laboratories, Inc

- The Female Health Company

- Cooper Surgical, Inc

- Allergan plc

- Cipla Limited

- Merck & Co. Inc

- Veru, Inc

- Organon Group of Companies

- Agile Therapeutics

- TherapeuticsmMD, Inc

- Afaxys, Inc

- Mithra Pharmaceuticals

- Abbvie

Segment by Type

- Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)

- Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

Segment by Application

- Female

- Male

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

The Contraceptives Drugs and Devices report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies' Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies' Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Global Contraceptives Drugs and Devices Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Contraceptives Drugs and Devices Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
1.2.3 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
1.3 Market by Application
1.3.1 Global Contraceptives Drugs and Devices Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Female
1.3.3 Male
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Contraceptives Drugs and Devices Market Perspective (2018-2029)
2.2 Contraceptives Drugs and Devices Growth Trends by Region
2.2.1 Global Contraceptives Drugs and Devices Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Contraceptives Drugs and Devices Historic Market Size by Region (2018-2023)
2.2.3 Contraceptives Drugs and Devices Forecasted Market Size by Region (2024-2029)
2.3 Contraceptives Drugs and Devices Market Dynamics
2.3.1 Contraceptives Drugs and Devices Industry Trends
2.3.2 Contraceptives Drugs and Devices Market Drivers
2.3.3 Contraceptives Drugs and Devices Market Challenges
2.3.4 Contraceptives Drugs and Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Contraceptives Drugs and Devices Players by Revenue
3.1.1 Global Top Contraceptives Drugs and Devices Players by Revenue (2018-2023)
3.1.2 Global Contraceptives Drugs and Devices Revenue Market Share by Players (2018-2023)
3.2 Global Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Contraceptives Drugs and Devices Revenue
3.4 Global Contraceptives Drugs and Devices Market Concentration Ratio
3.4.1 Global Contraceptives Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contraceptives Drugs and Devices Revenue in 2022
3.5 Contraceptives Drugs and Devices Key Players Head office and Area Served
3.6 Key Players Contraceptives Drugs and Devices Product Solution and Service
3.7 Date of Enter into Contraceptives Drugs and Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Contraceptives Drugs and Devices Breakdown Data by Type
4.1 Global Contraceptives Drugs and Devices Historic Market Size by Type (2018-2023)
4.2 Global Contraceptives Drugs and Devices Forecasted Market Size by Type (2024-2029)
5 Contraceptives Drugs and Devices Breakdown Data by Application
5.1 Global Contraceptives Drugs and Devices Historic Market Size by Application (2018-2023)
5.2 Global Contraceptives Drugs and Devices Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Contraceptives Drugs and Devices Market Size (2018-2029)
6.2 North America Contraceptives Drugs and Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Contraceptives Drugs and Devices Market Size by Country (2018-2023)
6.4 North America Contraceptives Drugs and Devices Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Contraceptives Drugs and Devices Market Size (2018-2029)
7.2 Europe Contraceptives Drugs and Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Contraceptives Drugs and Devices Market Size by Country (2018-2023)
7.4 Europe Contraceptives Drugs and Devices Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Contraceptives Drugs and Devices Market Size (2018-2029)
8.2 Asia-Pacific Contraceptives Drugs and Devices Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Contraceptives Drugs and Devices Market Size by Region (2018-2023)
8.4 Asia-Pacific Contraceptives Drugs and Devices Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Contraceptives Drugs and Devices Market Size (2018-2029)
9.2 Latin America Contraceptives Drugs and Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Contraceptives Drugs and Devices Market Size by Country (2018-2023)
9.4 Latin America Contraceptives Drugs and Devices Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Contraceptives Drugs and Devices Market Size (2018-2029)
10.2 Middle East & Africa Contraceptives Drugs and Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Contraceptives Drugs and Devices Market Size by Country (2018-2023)
10.4 Middle East & Africa Contraceptives Drugs and Devices Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceutical Industries Ltd
11.1.1 Teva Pharmaceutical Industries Ltd Company Detail
11.1.2 Teva Pharmaceutical Industries Ltd Business Overview
11.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Introduction
11.1.4 Teva Pharmaceutical Industries Ltd Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.1.5 Teva Pharmaceutical Industries Ltd Recent Development
11.2 Church & Dwight Co. Inc
11.2.1 Church & Dwight Co. Inc Company Detail
11.2.2 Church & Dwight Co. Inc Business Overview
11.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Introduction
11.2.4 Church & Dwight Co. Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.2.5 Church & Dwight Co. Inc Recent Development
11.3 Reckitt Benckiser Plc
11.3.1 Reckitt Benckiser Plc Company Detail
11.3.2 Reckitt Benckiser Plc Business Overview
11.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Introduction
11.3.4 Reckitt Benckiser Plc Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.3.5 Reckitt Benckiser Plc Recent Development
11.4 Pfizer, Inc
11.4.1 Pfizer, Inc Company Detail
11.4.2 Pfizer, Inc Business Overview
11.4.3 Pfizer, Inc Contraceptives Drugs and Devices Introduction
11.4.4 Pfizer, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.4.5 Pfizer, Inc Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Detail
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Contraceptives Drugs and Devices Introduction
11.5.4 Bayer AG Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.5.5 Bayer AG Recent Development
11.6 Mayer Laboratories, Inc
11.6.1 Mayer Laboratories, Inc Company Detail
11.6.2 Mayer Laboratories, Inc Business Overview
11.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Introduction
11.6.4 Mayer Laboratories, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.6.5 Mayer Laboratories, Inc Recent Development
11.7 The Female Health Company
11.7.1 The Female Health Company Company Detail
11.7.2 The Female Health Company Business Overview
11.7.3 The Female Health Company Contraceptives Drugs and Devices Introduction
11.7.4 The Female Health Company Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.7.5 The Female Health Company Recent Development
11.8 Cooper Surgical, Inc
11.8.1 Cooper Surgical, Inc Company Detail
11.8.2 Cooper Surgical, Inc Business Overview
11.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Introduction
11.8.4 Cooper Surgical, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.8.5 Cooper Surgical, Inc Recent Development
11.9 Allergan plc
11.9.1 Allergan plc Company Detail
11.9.2 Allergan plc Business Overview
11.9.3 Allergan plc Contraceptives Drugs and Devices Introduction
11.9.4 Allergan plc Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.9.5 Allergan plc Recent Development
11.10 Cipla Limited
11.10.1 Cipla Limited Company Detail
11.10.2 Cipla Limited Business Overview
11.10.3 Cipla Limited Contraceptives Drugs and Devices Introduction
11.10.4 Cipla Limited Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.10.5 Cipla Limited Recent Development
11.11 Merck & Co. Inc
11.11.1 Merck & Co. Inc Company Detail
11.11.2 Merck & Co. Inc Business Overview
11.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Introduction
11.11.4 Merck & Co. Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.11.5 Merck & Co. Inc Recent Development
11.12 Veru, Inc
11.12.1 Veru, Inc Company Detail
11.12.2 Veru, Inc Business Overview
11.12.3 Veru, Inc Contraceptives Drugs and Devices Introduction
11.12.4 Veru, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.12.5 Veru, Inc Recent Development
11.13 Organon Group of Companies
11.13.1 Organon Group of Companies Company Detail
11.13.2 Organon Group of Companies Business Overview
11.13.3 Organon Group of Companies Contraceptives Drugs and Devices Introduction
11.13.4 Organon Group of Companies Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.13.5 Organon Group of Companies Recent Development
11.14 Agile Therapeutics
11.14.1 Agile Therapeutics Company Detail
11.14.2 Agile Therapeutics Business Overview
11.14.3 Agile Therapeutics Contraceptives Drugs and Devices Introduction
11.14.4 Agile Therapeutics Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.14.5 Agile Therapeutics Recent Development
11.15 TherapeuticsmMD, Inc
11.15.1 TherapeuticsmMD, Inc Company Detail
11.15.2 TherapeuticsmMD, Inc Business Overview
11.15.3 TherapeuticsmMD, Inc Contraceptives Drugs and Devices Introduction
11.15.4 TherapeuticsmMD, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.15.5 TherapeuticsmMD, Inc Recent Development
11.16 Afaxys, Inc
11.16.1 Afaxys, Inc Company Detail
11.16.2 Afaxys, Inc Business Overview
11.16.3 Afaxys, Inc Contraceptives Drugs and Devices Introduction
11.16.4 Afaxys, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.16.5 Afaxys, Inc Recent Development
11.17 Mithra Pharmaceuticals
11.17.1 Mithra Pharmaceuticals Company Detail
11.17.2 Mithra Pharmaceuticals Business Overview
11.17.3 Mithra Pharmaceuticals Contraceptives Drugs and Devices Introduction
11.17.4 Mithra Pharmaceuticals Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.17.5 Mithra Pharmaceuticals Recent Development
11.18 Abbvie
11.18.1 Abbvie Company Detail
11.18.2 Abbvie Business Overview
11.18.3 Abbvie Contraceptives Drugs and Devices Introduction
11.18.4 Abbvie Revenue in Contraceptives Drugs and Devices Business (2018-2023)
11.18.5 Abbvie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Contraceptives Drugs and Devices Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Table 3. Key Players of Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Table 4. Global Contraceptives Drugs and Devices Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Contraceptives Drugs and Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Contraceptives Drugs and Devices Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Contraceptives Drugs and Devices Market Share by Region (2018-2023)
Table 8. Global Contraceptives Drugs and Devices Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Contraceptives Drugs and Devices Market Share by Region (2024-2029)
Table 10. Contraceptives Drugs and Devices Market Trends
Table 11. Contraceptives Drugs and Devices Market Drivers
Table 12. Contraceptives Drugs and Devices Market Challenges
Table 13. Contraceptives Drugs and Devices Market Restraints
Table 14. Global Contraceptives Drugs and Devices Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Contraceptives Drugs and Devices Market Share by Players (2018-2023)
Table 16. Global Top Contraceptives Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives Drugs and Devices as of 2022)
Table 17. Ranking of Global Top Contraceptives Drugs and Devices Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Contraceptives Drugs and Devices Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Contraceptives Drugs and Devices Product Solution and Service
Table 21. Date of Enter into Contraceptives Drugs and Devices Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Contraceptives Drugs and Devices Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Contraceptives Drugs and Devices Revenue Market Share by Type (2018-2023)
Table 25. Global Contraceptives Drugs and Devices Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Contraceptives Drugs and Devices Revenue Market Share by Type (2024-2029)
Table 27. Global Contraceptives Drugs and Devices Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Contraceptives Drugs and Devices Revenue Market Share by Application (2018-2023)
Table 29. Global Contraceptives Drugs and Devices Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Contraceptives Drugs and Devices Revenue Market Share by Application (2024-2029)
Table 31. North America Contraceptives Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Contraceptives Drugs and Devices Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Contraceptives Drugs and Devices Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Contraceptives Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Contraceptives Drugs and Devices Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Contraceptives Drugs and Devices Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Contraceptives Drugs and Devices Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Contraceptives Drugs and Devices Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Contraceptives Drugs and Devices Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Contraceptives Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Contraceptives Drugs and Devices Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Contraceptives Drugs and Devices Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Contraceptives Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Contraceptives Drugs and Devices Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Contraceptives Drugs and Devices Market Size by Country (2024-2029) & (US$ Million)
Table 46. Teva Pharmaceutical Industries Ltd Company Detail
Table 47. Teva Pharmaceutical Industries Ltd Business Overview
Table 48. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product
Table 49. Teva Pharmaceutical Industries Ltd Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 50. Teva Pharmaceutical Industries Ltd Recent Development
Table 51. Church & Dwight Co. Inc Company Detail
Table 52. Church & Dwight Co. Inc Business Overview
Table 53. Church & Dwight Co. Inc Contraceptives Drugs and Devices Product
Table 54. Church & Dwight Co. Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 55. Church & Dwight Co. Inc Recent Development
Table 56. Reckitt Benckiser Plc Company Detail
Table 57. Reckitt Benckiser Plc Business Overview
Table 58. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product
Table 59. Reckitt Benckiser Plc Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 60. Reckitt Benckiser Plc Recent Development
Table 61. Pfizer, Inc Company Detail
Table 62. Pfizer, Inc Business Overview
Table 63. Pfizer, Inc Contraceptives Drugs and Devices Product
Table 64. Pfizer, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 65. Pfizer, Inc Recent Development
Table 66. Bayer AG Company Detail
Table 67. Bayer AG Business Overview
Table 68. Bayer AG Contraceptives Drugs and Devices Product
Table 69. Bayer AG Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 70. Bayer AG Recent Development
Table 71. Mayer Laboratories, Inc Company Detail
Table 72. Mayer Laboratories, Inc Business Overview
Table 73. Mayer Laboratories, Inc Contraceptives Drugs and Devices Product
Table 74. Mayer Laboratories, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 75. Mayer Laboratories, Inc Recent Development
Table 76. The Female Health Company Company Detail
Table 77. The Female Health Company Business Overview
Table 78. The Female Health Company Contraceptives Drugs and Devices Product
Table 79. The Female Health Company Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 80. The Female Health Company Recent Development
Table 81. Cooper Surgical, Inc Company Detail
Table 82. Cooper Surgical, Inc Business Overview
Table 83. Cooper Surgical, Inc Contraceptives Drugs and Devices Product
Table 84. Cooper Surgical, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 85. Cooper Surgical, Inc Recent Development
Table 86. Allergan plc Company Detail
Table 87. Allergan plc Business Overview
Table 88. Allergan plc Contraceptives Drugs and Devices Product
Table 89. Allergan plc Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 90. Allergan plc Recent Development
Table 91. Cipla Limited Company Detail
Table 92. Cipla Limited Business Overview
Table 93. Cipla Limited Contraceptives Drugs and Devices Product
Table 94. Cipla Limited Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 95. Cipla Limited Recent Development
Table 96. Merck & Co. Inc Company Detail
Table 97. Merck & Co. Inc Business Overview
Table 98. Merck & Co. Inc Contraceptives Drugs and Devices Product
Table 99. Merck & Co. Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 100. Merck & Co. Inc Recent Development
Table 101. Veru, Inc Company Detail
Table 102. Veru, Inc Business Overview
Table 103. Veru, Inc Contraceptives Drugs and Devices Product
Table 104. Veru, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 105. Veru, Inc Recent Development
Table 106. Organon Group of Companies Company Detail
Table 107. Organon Group of Companies Business Overview
Table 108. Organon Group of Companies Contraceptives Drugs and Devices Product
Table 109. Organon Group of Companies Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 110. Organon Group of Companies Recent Development
Table 111. Agile Therapeutics Company Detail
Table 112. Agile Therapeutics Business Overview
Table 113. Agile Therapeutics Contraceptives Drugs and Devices Product
Table 114. Agile Therapeutics Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 115. Agile Therapeutics Recent Development
Table 116. TherapeuticsmMD, Inc Company Detail
Table 117. TherapeuticsmMD, Inc Business Overview
Table 118. TherapeuticsmMD, Inc Contraceptives Drugs and Devices Product
Table 119. TherapeuticsmMD, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 120. TherapeuticsmMD, Inc Recent Development
Table 121. Afaxys, Inc Company Detail
Table 122. Afaxys, Inc Business Overview
Table 123. Afaxys, Inc Contraceptives Drugs and Devices Product
Table 124. Afaxys, Inc Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 125. Afaxys, Inc Recent Development
Table 126. Mithra Pharmaceuticals Company Detail
Table 127. Mithra Pharmaceuticals Business Overview
Table 128. Mithra Pharmaceuticals Contraceptives Drugs and Devices Product
Table 129. Mithra Pharmaceuticals Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 130. Mithra Pharmaceuticals Recent Development
Table 131. Abbvie Company Detail
Table 132. Abbvie Business Overview
Table 133. Abbvie Contraceptives Drugs and Devices Product
Table 134. Abbvie Revenue in Contraceptives Drugs and Devices Business (2018-2023) & (US$ Million)
Table 135. Abbvie Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Contraceptives Drugs and Devices Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Contraceptives Drugs and Devices Market Share by Type: 2022 VS 2029
Figure 3. Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Features
Figure 4. Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Features
Figure 5. Global Contraceptives Drugs and Devices Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Contraceptives Drugs and Devices Market Share by Application: 2022 VS 2029
Figure 7. Female Case Studies
Figure 8. Male Case Studies
Figure 9. Contraceptives Drugs and Devices Report Years Considered
Figure 10. Global Contraceptives Drugs and Devices Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Contraceptives Drugs and Devices Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Contraceptives Drugs and Devices Market Share by Region: 2022 VS 2029
Figure 13. Global Contraceptives Drugs and Devices Market Share by Players in 2022
Figure 14. Global Top Contraceptives Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives Drugs and Devices as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Contraceptives Drugs and Devices Revenue in 2022
Figure 16. North America Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Contraceptives Drugs and Devices Market Share by Country (2018-2029)
Figure 18. United States Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Contraceptives Drugs and Devices Market Share by Country (2018-2029)
Figure 22. Germany Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Contraceptives Drugs and Devices Market Share by Region (2018-2029)
Figure 30. China Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Contraceptives Drugs and Devices Market Share by Country (2018-2029)
Figure 38. Mexico Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Contraceptives Drugs and Devices Market Share by Country (2018-2029)
Figure 42. Turkey Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Contraceptives Drugs and Devices Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 45. Church & Dwight Co. Inc Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 46. Reckitt Benckiser Plc Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 47. Pfizer, Inc Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 48. Bayer AG Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 49. Mayer Laboratories, Inc Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 50. The Female Health Company Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 51. Cooper Surgical, Inc Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 52. Allergan plc Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 53. Cipla Limited Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 54. Merck & Co. Inc Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 55. Veru, Inc Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 56. Organon Group of Companies Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 57. Agile Therapeutics Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 58. TherapeuticsmMD, Inc Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 59. Afaxys, Inc Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 60. Mithra Pharmaceuticals Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 61. Abbvie Revenue Growth Rate in Contraceptives Drugs and Devices Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs